CAMELIA MIHART: Open Payments
NPI 1942045380 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 19 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $96 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $149 |
| BridgeBio Pharma, Inc. | 3 | $129 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $87 |
| Regeneron Healthcare Solutions, Inc. | 2 | $63 |
| Edwards Lifesciences Corporation | 2 | $56 |
| Amgen Inc. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| HEARTFLOW, INC. | 1 | $21 |
Products named: Attruby, LifeVest, EVKEEZA, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, LOKELMA, REPATHA, VERQUVO, Kerendia.
Industry payments across OR — which companies pay providers there.
